FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell LymphomaBhupinder Mann, Richard Pazdur, John R. Johnson et al.|The Oncologist|2007Cited by 1.4k
FDA Drug Approval Summary: Bevacizumab (Avastin®) as Treatment of Recurrent Glioblastoma MultiformeMartin H. Cohen, Richard Pazdur, Yuan Li Shen et al.|The Oncologist|2009Cited by 646
FDA Drug Approval Summary: Gefitinib (ZD1839) (Iressa®) TabletsMartin H. Cohen, Richard Pazdur, Grant A. Williams et al.|The Oncologist|2003Cited by 576
United States Food and Drug Administration Drug Approval SummaryMartin H. Cohen, Richard Pazdur, Chenyi Liang et al.|Clinical Cancer Research|2004Cited by 500
Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia.Martin H. Cohen, Richard Pazdur, Grant Williams et al.|PubMed|2002Cited by 469